Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Oct 12.
Published in final edited form as: Biochemistry. 2018 Feb 2;57(22):3176–3190. doi: 10.1021/acs.biochem.7b01250

Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics

Xiang Zhai 1,, Thomas D Meek 1,*
PMCID: PMC10569748  NIHMSID: NIHMS1914990  PMID: 29336553

Abstract

Cruzain, an important drug target for Chagas disease, is a member of clan CA of the cysteine proteases. Understanding the catalytic mechanism of cruzain is vital to the design of new inhibitors. To this end, we have determined pH−rate profiles for substrates and affinity agents and solvent kinetic isotope effects in presteady-state and steady-state modes using three substrates: Cbz-Phe-Arg-AMC, Cbz-Arg-Arg-AMC, and Cbz-Arg-Ala-AMC. The pH−rate profile of kcat /Km for Cbz-Arg-Arg-AMC indicated pK1=6.6 (unprotonated) and pK2~9.6 (protonated) groups were required for catalysis. The temperature dependence of the pK=6.26.6 group exhibited a ΔHion  value of 8.4kcal/mol, typical of histidine. The pH−rate profile of inactivation by iodoacetamide confirmed that the catalytic cysteine possesses a pKa of 9.8. Normal solvent kinetic isotope effects were observed for both D2Okcat(1.62.1) and D2Okcat/Km(1.11.4) for all three substrates. Pre-steady-state kinetics revealed exponential bursts of AMC production for Cbz-Phe-Arg-AMC and Cbz-Arg-Arg-AMC, but not for Cbz-Arg-Ala-AMC. The overall solvent isotope effect on kcat  can be attributed to the solvent isotope effect on the deacylation step. Our results suggest that cruzain is unique among papain-like cysteine proteases in that the catalytic cysteine and histidine have neutral charges in the free enzyme. The generation of the active thiolate of the catalytic cysteine is likely preceded (and possibly triggered) by a ligand-induced conformational change, which could bring the catalytic dyad into the proximity to effect proton transfer.

Graphical Abstract

graphic file with name nihms-1914990-f0001.jpg


Cruzain is the major cysteine protease expressed by Trypanosoma cruzi, the causative agent of Chagas disease.1 With Chagas disease categorized as one of the most important neglected tropical diseases (NTDs), it is estimated that almost 8–9 million people are currently affected by this disease, with 50000 new cases annually reported in Latin America and the Caribbean.2 Present treatment options of Chagas disease are limited to benznidazole and nifurtimox, both of which have severe side effects and are inefficacious against long-term infections.3 The viability of cruzain as a drug target for new trypanocidal agents was demonstrated both in cell culture4,5 and in animal models,6,7 although its exact physiological role remains unclear. Recent studies have suggested that cruzain is potentially involved in immune evasion through its proteolysis of NF-κB P65,8 and the activation of latent TGF-β that induces increased infectivity of T. cruzi.9

Extensive efforts over the past three decades to develop inhibitors or covalent inactivators of cruzain have encompassed structure-based design, high-throughput screening, and virtual screening.10 The most successful inhibitor developed so far is K11777, which is comprised of a phenylalanyl-homophenylalanyl dipeptide “scaffold” linked to an electrophilic vinyl sulfone warhead that forms an irreversible Michael adduct with the eponymous active-site cysteine (Figure 1).11 K11777 cures Chagas disease in mouse models and protects dogs from cardiac damage during T. cruzi infection.12 However, preclinical studies of K11777 were halted because of its poor tolerability in primates and dogs even at low doses, which may be attributable to its irreversible mode of inactivation.

Figure 1.

Figure 1.

X-ray crystal structure of cruzain complexed with the irreversible inhibitor K11777, demonstrating the formation of a covalent bond between the active-site Cys25 and the α-carbon of the vinyl sulfone warhead.11 Protein Data Bank entry 2OZ2.

While the development of new cruzain inhibitors has been extensive, no detailed studies of the catalytic mechanism of cruzain exist. Sequence analysis and substrate profiling studies indicate that cruzain is a member of the cathepsin L-like papain family and belongs to clan CA of the cysteine proteases.13,14 The active sites of cysteine proteases contain a catalytic cysteine-histidine “dyad” that exists as either a neutral Cys-SH:His or a thiolate-imidazolium ion pair Cys–S:H-His+ species in the free enzyme. The initial protonation state of this catalytic dyad has been the subject of considerable debate.1518 Only recently has the catalytic mechanism of cruzain been investigated by molecular dynamics. In that study, an imidazolium-thiolate catalytic dyad exists in ligand-free cruzain, and the imidazolium ion of active-site His162 protonates the amide nitrogen prior to attack of the thiolate Cys25 on the amide carbonyl group.19 The catalytic mechanism of cysteine proteases involves two discrete half-reactions: the acylation of the active-site cysteine by the scissile carbonyl of the substrate with release of the amine product and the subsequent hydrolysis of the enzyme−peptide thioester (deacylation) to produce the carboxylate product. During acylation, the imidazolium ion of the active-site histidine provides the proton to the leaving amine (Scheme 1). Kinetic and structural analysis of papain is consistent with a Cys-S:H-His+ ion pair in the free enzyme.2023 Kinetic studies by Schneck et al. demonstrated that for human cathepsin C, like papain, the thiolate-imidazolium ion pair predominates in the active site (Scheme 1) in which the pK values for the Cys (4.3) and His (6.5) conform to “reverse protonation” of these residues, and the observed inverse solvent kinetic isotope effect for kcat /Km is consistent with enrichment of the thiolate ion in D2O in the free enzyme.24 However, in other cysteine proteases/hydrolases, such as ubiquitin-specific protease 1 (USP1), a neutral Cys-SH:His dyad exists in the free enzyme, as indicated by normal sKIEs, and the binding of its protein substrate induces apparent proton transfer from Cys-SH to the His to initiate catalysis.25 Here we investigate in detail the catalytic mechanism of cruzain by pH−rate profiles and the measurement of solvent kinetic isotope effects on steady-state and pre-steady-state kinetics of the proteolytic reaction of different dipeptide substrates.

Scheme 1.

Scheme 1.

Potential Chemical Mechanisms for Cruzain of Attack of Thiolate on a Peptide Substrate Involving a Thiolate-Imidazolium or Neutral Cysteine-Histidine Dyad

EXPERIMENTAL PROCEDURES

Materials.

HisPur Ni-NTA Superflow Agarose was purchased from ThermoFisher. HiTrap Q Sepharose FF columns were purchased from GE Healthcare. Deuterium oxide (≥99.9% gram atom D) was purchased from Cambridge Isotope Laboratories. Deuterium chloride [35% (w/w), 99% D], sodium acetate, sodium deuterium oxide [40% (w/w), 99% D], TAPSO, TEA, DEA, DEPC, MES, MMTS, disodium EDTA, glycerol, and sucrose were purchased from Sigma-Aldrich. DNase I was purchased from Roche. Z-FR-AMC was purchased from Biotium. Z-RR-AMC and Z-RA-AMC were purchased from Bachem or Enzo. All other chemicals were reagent grade or better and used without further purification.

Enzyme Preparations.

General procedures for cruzain expression, purification, and activation were performed according to published protocols26 with some modifications.

Protein Expression.

The plasmid encoding the C-terminally truncated procruzain (Δc; GenBank entry M84342.1) was a generous gift from C. S. Craik. The primer 5’-GCCTTGTCAAGGAGGCGGCGAGCTCCGCGGTGGTCGG-3’ was used to generate the G208A mutant of cruzain. The sequence of this mutant plasmid was confirmed by Eton Bioscience. ArcticExpress (DE3) cells were used as the expression strain. After inoculation with frozen glycerol stocks of transformed ArcticExpress cells, small cultures (5 mL) of Luria broth containing carbenicillin (100 μg/mL) and gentamycin (20 μg/mL) were grown overnight at 37 °C to saturation. Five milliliters of this starting culture was added to 1 L of Terrific Broth medium containing the same amount of carbenicillin and gentamycin. After being grown for ~6 h (OD600 = 0.6), cultures were moved to 18 °C, and protein expression was initiated by adding 0.4 mM isopropyl β-d-1-thiogalactopyranoside. Cells were harvested after overnight expression, and the cell pellets were stored at −20 °C.

Protein Purification and Activation of Cruzain from Procruzain.

Frozen cell pellets were thawed and resuspended at a concentration of 50 mL/L of growth medium in lysis buffer [50 mM Tris (pH 10), 300 mM NaCl (buffer A), containing 10 mM imidazole, 1 mM CaCl2, 1 mM MgSO4, 1 μM DNase I, 1 mM phenylmethanesulfonyl fluoride (PMSF), and 2 mM methylmethanethiosulfonate (MMTS)]. After resuspension, samples were lysed via sonication (ThermoFisher model FB505 sonicator) with 20 s pulses (50% amplitude) followed by 59 s intervals at 50% amplitude for a 10 min total period of sonication. The resulting lysate was centrifuged at 17000g for 1 h. The supernatant was passed through a 0.2 μm filter prior to being loaded onto a HisPur Ni-NTA column (ThermoFisher Scientific) equilibrated with buffer A. After being extensively washed with buffer A containing 50 mM imidazole, bound procruzain was eluted with buffer A containing 500 mM imidazole. MMTS at a final concentration of 5 mM was added to each of the fractions containing His6-tagged procruzain upon elution.

Fractions containing procruzain were combined and dialyzed overnight at 4 °C against 2 L of activation buffer [50 mM sodium acetate (pH 5.0), 100 mM NaCl, and 0.1 mM disodium EDTA] in the absence of reducing agents. The resulting cloudy solution was transferred into 50 mL conical centrifuge tubes (1 L growth medium per 50 mL activation sample). Autoproteolysis was initiated by addition of 10 mM DTT, followed by incubation at 37 °C for 1–3 h until the dialysate solution became completely clear. The clarified solution was then dialyzed against 50 mM Tris (pH 8.0) to remove salts, and this dialysate was loaded onto two 5 mL HiTrap Q FF columns connected in a series. Cruzain was eluted with 500 mL of 50 mM Tris (pH 8.0) buffer containing a gradient of 50–400 mM NaCl. The resulting cruzain was flash-frozen and stored at −80 °C in the eluant containing 20% glycerol, at a protein concentration of 5 mg/mL. The protein was judged to be homogeneous with >95% purity based on sodium dodecyl sulfate−polyacrylamide gel electrophoresis. The N-terminus of the protein (H2N-APAAVD) was confirmed by Edman sequencing performed by the Protein Chemistry Laboratory at Texas A&M University. Activation of cruzain fractions required removal of MMTS. This was accomplished by five rounds of spin dialysis versus assay buffer containing 5 mM DTT using a 10000 molecular weight cutoff Amicon centrifuge tube. The final enzyme concentration was determined by absorbance at 280 nm using an ε280 value of 60430 M−1 cm−1 (oxidized Cys) or 59930 M−1 cm−1 (reduced Cys) calculated from the ProtParam tool available on the Expasy server.27

Enzyme Assays.

Unless otherwise noted, all enzyme assays were performed at 25 °C. Initial rates of the peptidolytic reaction catalyzed by cruzain were measured by monitoring the fluorescence generated by cleavage of the dipeptide−AMC bond. Assays were conducted in 96-well plates (Greiner, flat-bottom, clear black plates) in a total volume of 250 μL, containing either 50 mM sodium acetate, 50 mM MES, and 100 mM TEA (pH 3.5–8.0) or 50 mM MES, 50 mM TAPSO, and 100 mM DEA (pH 5.5–9.8), each mixed with 1 mM CHAPS, 1 mM Na2EDTA (Overlap Buffers), 5 mM DTT, and 2 or 10% (v/v) DMSO. Substrates were dissolved in 100% DMSO and then diluted 10-fold such that when they were added to reaction mixtures, the final DMSO concentration was either 2% (v/v) (as used in the pH studies such that high levels of DMSO would not obscure the acid/base dissociation constants) or 10%. Reactions were initiated via the addition of 5 μL of cruzain (final concentrations of 0.017–3.0 nM). Fluorescence was measured on either a SpectraMax M5 (Molecular Devices) or a Synergy HTX (Biotek, Wisnooki, VT) microplate reader λex=360nm;λem=460nm. Initial rates were determined from continuous kinetic time courses and calculated from the earliest time points, typically in <10 min.

pH−rate Profiles.

The pH dependence of kcat and kcat/Km for cruzain-catalyzed peptidolysis of Z-FR-AMC, Z-RR-AMC, and Z-RA-AMC was investigated at pH 3.5–10 with two different three-component mixed buffer systems. Cruzain was preincubated for 30 min at each pH, after which the pH was readjusted to 7.0 to determine the stability of the enzyme over the experimental pH range. Cruzain activity was unchanged from pH 4.5 to 9.5, affording a wide range for the evaluation of pH−rate profiles. To maintain a constant ionic strength of 0.1, 50 mM sodium acetate/MES and 100 mM TEA were used for pH 3.5–8.0 and 50 mM MES/TAPSO and 100 mM DEA were used for pH 5.5–10.0 (Overlap Buffers);28 the pH was adjusted with small aliquots of concentrated HCl or NaOH. There were no significant differences in values of kcat and Km at the overlap pH points for the two buffers. Typical enzyme concentrations (wild type) used in kinetic measurements were 17 pM, 0.17–1.7 nM, and 1–70 nM for Z-FR-AMC, Z-RR-AMC, and Z-RA-AMC, respectively. Concentrations for the E208A mutant of cruzain used in kinetic measurements were 17 pM, 3.4–34 nM, and 20–1400 nM for Z-FR-AMC, Z-RR-AMC, and Z-RA-AMC, respectively. The temperature dependence of the kcat/Km of wild-type (WT) cruzain was determined in a single mixed buffer of 50 mM MES/TAPSO, 100 mM DEA, 1 mM Na2EDTA, and 1 mM CHAPS (pH 4.5–7.5) at 25–40 °C. The apparent pH for the buffer was determined at each temperature used, and data for logkcat /Km versus pH were corrected for a diminution in pH of 0.012 unit/°C.

Solvent Kinetic Isotope Effects.

To determine the solvent kinetic isotope effects of cruzain substrates, Overlap Buffers were prepared in 100% D2O and adjusted to the desired pD using either sodium deuteroxide or deuterium chloride (pD 3.5–10). The calculated final percentage of deuterium in these buffers was 93%, based on precedent.24 pD values were determined as the measured pH value + 0.4.29 Values of kcat  and kcat /Km for Z-FR-AMC, Z-RR-AMC, and Z-RA-AMC were acquired from initial rate studies in deuterated Overlap Buffers also containing 5 mM DTT and 2% DMSO. Solvent kinetic isotope effects were then ascertained from comparison of the pH- and pD-independent values of these kinetic parameters as described in Data Analysis. To rule out any viscosity effect of D2O on the initial rate, the kinetic parameters kcat and kcat/Km were measured with 0.5–100 μM Z-FR-AMC in Overlap Buffers containing 5 mM DTT, 10% DMSO, and either 0–25% (w/v) sucrose or 0–12% (w/v) glycerol.

Inactivation of Cruzain by lodoacetamide and Diethylpyrocarbonate.

WT cruzain (1–3 nM) was preincubated for 0–80 min with 0–1 mM iodoacetamide at pH 5.5–10 in 50 mM MES, 50 mM TAPSO, 100 mM DEA, and 10% DMSO. Because DTT reacts with iodoacetamide and potentially with DEPC, it was omitted from the preincubation and assay mixtures. Likewise, 1–3 nM WT cruzain was preincubated for 0–5 min with 0–100 μM DEPC (dissolved in either 100% DMSO or ice-cold ethanol) at pH 5.5–10 in 50 mM MES, 50 mM TAPSO, 100 mM DEA, and 10% DMSO. Aliquots (5 μL) of both types of preincubation mixtures were diluted into 250 μL assay mixtures containing Overlap Buffers (pH 7.5) and 10 μM Z-FR-AMC [10% (v/v) DMSO], and residual cruzain activity was measured.

Pre-Steady-State Kinetics.

Pre-steady-state kinetics for cruzain-catalyzed reactions of 0.5–10 μM Z-FR-AMC and 1.6–60 μM Z-RR-AMC were conducted at 25 °C and pH(D) 7.5. Time courses (0.002–0.2 s) of AMC production were measured using a Kintek AutoSF-120 stopped-flow fluorimeter (Kintek, Snow Shoe, PA), where fluorescence readings of AMC (excitation at 348 nm and emission at 438 nm with a 400 nm cutoff filter) were collected and analyzed by Kintek software. Reaction mixtures contained 50 mM MES, 50 mM TAPSO, 100 mM DEA, 1 mM CHAPS, and 1 mM Na2EDTA and were prepared in either H2O or D2O. Solutions of WT cruzain (0.5 μM) and the substrate were loaded into separated syringes that each contained buffer, 10% DMSO, and 5 mM DTT. Fluorescence time courses were comprised of 1000 time points for each fixed substrate concentration, and time courses of AMC formation (millivolts) were converted to nanomolar concentrations of product formed following calibration of the system with known concentrations of AMC. Calibration of the stopped-flow fluorimeter was ascertained by measurement of the concentration of free AMC found in each solution of substrate, and two kinetic traces were generated: one background trace measuring the signal of the contaminating free AMC present in the substrate and one reaction trace monitoring the newly generated AMC from the cleavage of the peptide substrate by cruzain. After the background had been subtracted, the voltage signals were converted into concentration according to a calibration curve generated from solutions containing known concentrations of AMC. Separate experiments were conducted to determine the binding constant Kia for both substrates in H2O and D2O using a larger range of substrate concentrations (0–80 μM).

Data Analysis.

Values of kcat  and Km for cruzain-catalyzed reactions of the fluorogenic peptide substrates were determined by nonlinear least-squares fits of the initial velocity data to eq 1 using GraphPad Prism 6.0 or SigmaPlot 12.0 (Systat, Inc.). For eq 1, kcat  is the turnover number, Et is the concentration of active sites of cruzain, and Ka is the Michaelis constant for substrate A.

vEt=kcat[A]Ka+[A] (1)

In enzyme inactivation studies using affinity agents, residual cruzain activity vi/v0 plotted against time (eq 2) was used to obtain pseudo-first-order rate constants of inactivation kobs  at each inactivator concentration (I). The second-order rate constants, kinact /KI, for inactivation of cruzain by iodoacetamide were determined from the slopes of the replots of the pseudo-first-order rate constants versus iodoacetamide concentration, as fitted to eq 3a. Similarly, for DEPC, values of kobs versus time were fitted to eq 3b, and for both equations, kinact  and KI are the maximal rate of inactivation and the concentration of inactivator at which the rate of inactivation is half that of kinact , respectively.

lnviv0=kobst (2)
kobs=kinact KI[I] (3a)
kobs=kinact [I]KI+[I] (3b)

Data for all pH profiles were fitted as semilogarithmic plots to eq 4

y=c1+10pK1pH)+10pHpK2) (4)

where y is the observed kinetic parameter kcat/Km or kcat,c is the pH-independent value of y, and pK1 and pK2 are the apparent acid and base dissociation constants, respectively. For plots of kcat /Km versus pH(D) in which a “hollow” was observed, rather than apparent slopes of 1 and −1 characteristic of “bell-shaped” curves (eq 4), data were fitted to eq 5

kcatKm=c(1+10(pKapH))(1+10(pK1pH))(1+10(pKapH)β) (5)

where c is the pH-independent value of kcat /Km,Ka=αK1, where α is a collection of rate constants, K1 is the apparent acid dissociation constant, and β is a collection of rate constants that comprise the “stickiness ratio” for the substrate.30

The solvent kinetic isotope effects (sKIEs, EC) were calculated using eq 6

EC=cHcD1Fi (6)

where cH and cD are pH(D)-independent values of kcat/Ka or kcat  and Fi is the fraction of D2O used in the studies. Error propagation on calculated values of the sKIEs was determined from the ratios of the experimental values in H2O and D2O, by the use of eq 7

error propagation=δcHfcH+δcDfcD+δcFifcFi (7)

where δcH,δcD, and δcFi are experimental standard deviations of cH,cD, and cFi, respectively, and f/cH,f/cD, and f/cFi are the respective partial derivatives of eq 6.

Pre-steady-state data were fitted to a single-exponential function (eq 8) for each fixed concentration of Z-FR-AMC and Z-RR-AMC. In eq 8, P is product AMC formed (bound or free, micromolar), vss is the apparent steady-state rate, t is the time in seconds, β is the apparent burst amplitude, λ is the apparent rate of the exponential phase, and C is a constant of calibration.24 Steady-state rates, burst amplitudes, and transient rate constants were replotted at each concentration of substrate ([A]) using eqs 1,9, and 10, respectively, for which β is the burst amplitude (micromolar), λ is the transient rate constant (inverse seconds), kcat  is the steady-state turnover number (inverse seconds), kac and kdac are the apparent rate constants of the acylation and deacylation half-reactions, respectively (inverse seconds), Et is the cruzain concentration (micro-molar), and Ka and Kia are the Michaelis and dissociation constants of the substrate, respectively.

P=vsst+β1eλt+C (8)
β=kcat[A]kdacKa+[A]2Et (9)
λ=kac+kdac[A]+kdacKiaKia+[A] (10)
P=kcatEt[A]Ka+[A]t+kcat[A]kdacKa+[A]2Et1ekac+kdac[A]+kdacKiaKia+[A]+C (11)

Additionally, pre-steady-state data conforming to a singleexponential function were fitted globally to eq 11, in which more than 10000 data points representing pre-steady-state time courses for all fixed concentrations of Z-FR-AMC or Z-RR-AMC were simultaneously fitted. In all cases, the most appropriate fit for each equation was determined by an F-test analysis of the results of nonlinear regression.

Nomenclature.

Isotope effects are expressed using the notation of Cook, Cleland, and Northrop.31,32 Solvent kinetic and equilibrium isotope effects measured on kcat,kcat/Ka, and other kinetic parameters are notated as leading superscripts, designated as “D” for the sake of simplicity, with the variable substrate as the right subscript.

RESULTS AND DISCUSSION

Steady-State Kinetics and Substrate Specificity.

Initial velocity data for the three fluorogenic dipeptide substrates are summarized in Table 1. The value of kcat  is largest for Z-FR-AMC (17 s−1), which is more than twice than that of Z-RR-AMC, suggesting a better accommodation for a Phe residue at the P233 position than for Arg. The possibility that cruzain may accommodate both Phe and Arg at the P2 position of dipeptide substrates has been attributed to the role of Glu208 found in the S2 binding subsite (Figure 1). It was shown from structural studies that Glu208 points toward a P2 Arg residue on the substrate but away from Phe in the P2 position of the substrate, as depicted in Figure 1, for which the irreversible inactivator K11777 (N-methyl-piperazine-Phe-homoPhe-vinylsulfone-phenyl) contains a phenylalanine as its P2 residue.11 The kcat  of Z-RA-AMC (0.89 s−1) is nearly 20-fold lower than that of Z-FR-AMC, indicating that a larger residue at the P1 position is preferred for catalysis, while a hydrophobic residue at P2 is more favorable than a charged one. Values of kcat /Km for the three substrates range from 104 to 107 M−1 s−1, wherein kcat /Km for Z-FR-AMC is 3 orders of magnitude larger than the lowest value of kcat/Km for Z-RA-AMC. On the basis of the rank order of kcat/Km values for the three different substrates, cruzain clearly prefers substrates with a large, charged residue at the P1 position and a hydrophobic residue in the P2 position, consistent with findings from a comprehensive analysis of peptide substrate specificity.14

Table 1.

Steady-state Kinetic Parameters for Cruzain-catalyzed Proteolytic Reactions of Z-FR-AMC, Z-RR-AMC and Z-RA-AMC.a

Wildtypeb E208Ac
Substrate kcat (s1) Km(μM) kcat/Km(M1s1) kcat(s1) Km(μM) kcat/Km(M1s1)
Z-FR-AMC 17 ± 2 0.62 ± 0.02 (2.7 ± 0.4) × 107 21 ± 1 1.6 ± 0.1 (1.3 ± 0.1) × 107
Z-RR-AMC 7.2 ± 0.1 3.7 ± 0.4 (1.9 ± 0.2) × 106 0.27 ± 0.01 45 ± 4 (6.0 ± 0.1) × 103
Z-RA-AMC 0.89 ± 0.06 38 ± 2 (2.3 ± 0.3) × 104 0.017 ± 0.001 163 ± 3 (1.0 ± 0.1) × 102
a

Under assay conditions of 50 mM MES, 50 mM TAPSO, 100 mM DEA, 1 mM CHAPS, 1 mM EDTA, 5 mM DTT, 2% (v/v) DMSO, pH 7.5 and 25 °C.

b

The errors for wildtype-catalyzed reactions were determined from the average of kinetic parameters determined in duplicates.

c

The errors for E208A cruzain mutant-catalyzed reactions are the standard deviations determined from the nonlinear least squares fits of the kinetic data.

Mutagenesis of Glu208.

We prepared the E208A mutant of cruzain to investigate the role of this residue in recognition of the P2 substituent of substrates. For Z-FR-AMC, kcat for WT and E208A cruzain is equivalent, Km is increased 2.5-fold, and kcat/Km is halved for the mutant enzyme (Table 1). Accordingly, while the E208A mutant “recognizes” Z-FR-AMC less effectively than wild-type cruzain does, turnover of the substrate is comparable, suggesting that once bound, mutant cruzain processes Z-FR-AMC at rates similar to that of the wild-type enzyme. However, mutation of Glu208 exhibited profound effects on all three kinetic parameters of substrates bearing an Arg residue at the P2 position. Diminutions by 300- and 200-fold in the kcat/Km values of Z-RR-AMC and Z-RA-AMC, respectively, were observed for the E208A mutant cruzain compared to that of the wild type, suggesting that ion pairing between Glu208 and P2 Arg is essential for recognition of these substrates. This is also reflected in values of Km, which are increased for Z-RR-AMC (10-fold) and Z-RA-AMC (4-fold). Values of kcat for mutant cruzain, unlike Z-FR-AMC, are greatly diminished for the substrates containing Arg at P2: Z-RR-AMC (26-fold lower) and Z-RA-AMC (50-fold lower).

pH−rate Profiles.

The pH–rate profiles for Z-FR-AMC, Z-RR-AMC, and Z-RA-AMC with wild-type cruzain over a pH range of 3.5–10.0 are shown in Figure 2 (blue plots) with results summarized in Table 2. For this pH range, there are no prototropic groups on any of the substrates studied. The plot of kcat versus pH (3.5–10.0) for Z-FR-AMC was apparently invariant with pH, while those of Z-RR-AMC and Z-RA-AMC decreased with apparent slopes of +1 and −1 at low and high pH, respectively. When fitting to eq 4 was performed, kcat decreased upon protonation of an enzymatic residue with pK1 values of 5.5 and 6.1, for Z-RR-AMC and Z-RA-AMC, respectively, and upon deprotonation of an enzymatic residue with a pK2 of ≥ 10. For Z-FR-AMC, the plot of kcat/Km versus pH was characterized by a “hollow” as pH decreased, with an apparent slope of less than +1. This plot indicates that Z-FR-AMC is a “sticky” substrate;30 that is, the substrate desorbs from its Michaelis complex at a rate equal to or less than that of its progression through catalysis.

Figure 2.

Figure 2.

Plots of pH(D) (pL) rate profiles of kcat (top) and kcat/Km (bottom) for cruzain-catalyzed hydrolysis of Z-FR-AMC (circles), Z-RR-AMC (squares), and Z-RA-AMC (diamonds). Blue and red symbols are for data obtained in H2O and D2O, respectively. Lines drawn through the experimental data of plots of kcat vspH(D) are from fitting to eq 4, while lines drawn through the experimental data of plots of kcat /Km vs pH(D) are from fitting to eq 4 (solid line, dashed line for Z-FR-AMC) or eq 5 (solid line for Z-FR-AMC). Error bars represent standard deviations from two independent measurements.

Table 2.

pH-rate Profiles and Solvent Kinetic Isotope Effects from Steady-state Kinetics of Wild-Type Cruzain.a

kcat  kcat/Km sKIE b
Substrate Solvent Eq. pK1 pK2 c c(s1) Eq. pK1 pK2 pKa c(μM1s1) β D2Okcat  D2O(kcatKm)
Z-FR-AMC H2O n.a. e n.d. d n.d. 14.5 ± 0.4 4 6.4 ± 0.7 n.d. n.d. 24 ± 2 1.88 ± 0.06 1.4 ± 0.1
5 6.2 ± 0.4 n.d. 5.8 ± 0.4 26 ± 2 70 ± 50
D2O n.a. n.d. n.d. 7.7 ± 0.1 4 6.0 ± 0.1 n.d. n.d. 17 ± 1
5 6.0 ± 0.1 n.d. 5.2 ± 0.2 17.4 ± 0.7 34 ± 8
Z-RR-AMC H2O 4 5.5 ± 0.1 ≥ 10 7.4 ± 0.2 4 6.6 ± 0.1 9.6 ± 0.1 n.a. 0.23 ± 0.01 n.a. 1.76 ± 0.06 1.15 ± 0.08
D2O 4 5.9 ± 0.1 ≥ 10 4.2 ± 0.1 4 7.4 ± 0.1 ~ 10 n.a. 0.2 ± 0.01 n.a.
Z-RA-AMC H2O 4 6.1 ± 0.1 ≥ 10 0.88 ± 0.03 4 6.2 ± 0.1 ≥ 10 n.a. 0.024 ± 0.001 n.a. 1.73 ± 0.07 1.09 ± 0.07
D2O 4 6.4 ± 0.1 ≥ 10 0.51 ± 0.01 4 6.7 ± 0.1 ≥ 10 n.a. 0.022 ± 0.001 n.a.

This result is unsurprising given that the value of kcat/Km for Z-FR-AMC is near the limit of diffusion control (2.4 × 107 M−1s−1), and the pH independence of the values of kcat. For sticky substrates, apparent values of pK are perturbed in plots of kcat/Km versus pH, resulting in “hollows” in the plots, and do not reflect the true acid or base dissociation constants of the enzymatic residues involved in binding and catalysis.30 However, fitting of these data to eq 5 uncovered a pK1 value of 6.2 associated with an enzymatic group that must be unprotonated for substrate binding. In contrast, the plots of kcat/Km versus pH for Z-RR-AMC and Z-RA-AMC exhibited apparent slopes of +1 and −1 at low and high pH, respectively. Fitting of plots of kcat/Km versus pH to eq 4 resulted in pK1 values of 6.6 and 6.2 for Z-RR-AMC and Z-RA-AMC, respectively. The basic dissociation constant, pK2, while poorly determined at these extreme values of pH, equaled ~10 for both substrates. The current pH profiles are similar to those previously reported for cruzain in which pH–rate profiles were also substrate-dependent.34

Scheme 2 describes a model for the pH−rate profiles for wild-type cruzain. HE is the monoprotonated form of cruzain to which all three substrates bind k1 to form the competent Michaelis complex HEA, which proceeds kac to form the thioester form of cruzain (F), followed by deacylation kdac to regenerate the free enzyme. Plots of kcat/Km versus pH report on the rate of the acylation half-reaction, measure the enzymatic rate at substrate concentrations approaching zero, and describe the protonation state of free enzyme HE. Here, protonation of an enzymatic group with a pK1 of ~6 or deprotonation of the enzymatic group with a pK2 of ~10 produces HEH+ or E, respectively, each of which is incapable of catalysis. However, a sticky substrate (A) may also bind to HEH+k7, and with loss of a proton k5 from the group of pK1, the resulting HEA complex is catalytically competent.30,35 In addition, for a sticky substrate, the proton of the HEA complex may not be subject to removal at high pH such that kcat  is apparently independent of pH. The “hollow” observed for the plot of kcat /KZ-FR-AMC  versus pH arises from protonation of the HEA complex k6, and the flattening of the curve is due to perturbation of the value of pK1 where Ka=k1/k21+k8/k5K1. 30,35 Fitting of the plot of kcat /KZ-FR-AMC  versus pH using eq 5 provided an estimate of the stickiness of the substrate from the parameter β=1+kac/k2=70±50, indicating that Z-FR-AMC proceeds to form acylated cruzain ~70 times faster than it desorbs from the HEA complex.

Scheme 2.

Scheme 2.

Kinetic Model for pH−Rate Profiles for Cruzain

For cruzain, the essential basic group with a pK1 of 6.2–6.6 could be the active-site histidine, or given the salience of an enzymatic group of pK1 in the pH–rate profiles of substrates bearing an Arg at the P2 position, this could reflect a carboxylate group such as that of Glu208. We therefore investigated the pH dependence of the E208A mutant of cruzain for Z-FR-AMC, Z-RR-AMC, and Z-RA-AMC (Figures S1S5). The semilogarithmic profile of kcat /KZ-FR-AMC versus pH for E208A cruzain was similar to that of the wild type except that the curve exhibited less of a “hollow” than WT cruzain did, suggesting that Z-FR-AMC is a less sticky substrate with the mutant enzyme (Figure S1). For Z-RR-AMC and Z-RA-AMC, the pH−rate profiles indicated that a residue with a pK of ~5.3 and ~6.1, respectively, must be unprotonated for catalysis, and that the pH-independent values of kcat and kcat/Km are almost 20-fold lower than that of wild-type cruzain (Figures S2 and S3). These results rule out Glu208 as the residue corresponding to pK1.

Solvent Kinetic Isotope Effects under Steady-State Conditions.

Solvent kinetic isotope effects from the kinetic parameters kcat and kcat/Km were acquired from pD–rate profiles generated under conditions identical to those described above using Overlap Buffers prepared in D2O. Plots of kcat  and kcat /Km versus pD (Figure 2, red points) were identical in form to their counterparts in water, and each plot had been apparently right-shifted by approximately 0.5–0.8 unit for pK1, due to the solvent equilibrium isotope effect29 on enzymatic residues (Table 2). A ΔpK value of 0.5 is typical for all enzymatic residues except cysteine.29,36 The pK2 values in both the kcat  and kcat/Km profiles were poorly determined because of the lack of data beyond pD = 10. As in H2O for Z-FR-AMC, kcat  was pD-independent, while kcat /Km versus pD was best fitted to eq 5 because of the presence of a “hollow” in the profile. In D2O, the stickiness ratio was half that obtained in H2O, indicating that a solvent isotope effect on kcat /Km slowed catalysis with respect to substrate desorption. Solvent kinetic isotope effects were ascertained from the pH(D)-independent values of kcat  and kcat /Km. Normal sKIEs were found for kcat  with the following values: D2Okcat =1.88±0.06 for Z-FR-AMC, D2Okcat =1.76±0.06 for Z-RR-AMC, and D2Okcat =1.73±0.07 for Z-RA-AMC. The sKIEs for kcat /Km were normal and only slightly greater than unity (1.1–1.4) for all three substrates (Table 2). These results differ from the sKIEs observed on cathepsin C24 and papain,2022 both of which exhibited D2Okcat 2 and D2Okcat/Km<1.0 (discussed below). The kinetic parameters kcat  and kcat /Km were unchanged in the presence of either 0–25% (w/v) sucrose or 0–12% (w/v) glycerol, indicating that the experimental normal sKIEs were not a result of the increased viscosity of D2O, which is comparable to the viscosity of an aqueous solution of 9% (w/v) glycerol.37

Temperature Dependence of pK1.

The temperature dependence of acid dissociation constants provides an additional method for identification of an enzymatic group due to its distinctive values of enthalpy of ionization. Because the dissociation constant for the enzyme side chain with a pK1 of 6 could be observed in the plot of kcat /KZ-RR-AMC  versus pH at 25 °C, we investigated the temperature dependence of pK1 from plots of logkcat /KZ-RR-AMC  versus pH obtained at 25–40 °C. The resulting average values (n ≥ 2) of pK1 decreased from 6.2 ± 0.1 at 25 °C to 5.9 ± 0.1 at 40 °C (corrections for the temperature dependence of pH for the buffer used were applied at each temperature). The plot of pK1 versus 1/T was linear (Figure 3). The temperature dependence of acid dissociation constant pK1 was fitted to eq 12

pK1=ΔHionRTΔSionR (12)

where T is the temperature in Kelvin, R is the universal gas constant, and ΔHion  and ΔSion  are the values of enthalpy and entropy of ionization, respectively.

Figure 3.

Figure 3.

Effect of temperature on the acid dissociation constant pK1 from plots of logkcat /KZ-RR-AMC  (top line) and logkcat  (bottom line) vs pH. Values of pK1(n2) vs 1/T (Kelvin) were fitted to eq 12, from which ΔHion  values of 8.4 ± 0.2 and 7.1±0.1kcal/mol and a ΔSion  of 0calmol1K1 were obtained.

The fitting of the temperature-dependent pK1 data resulted in values of 8.4±0.2kcal/mol and 1019calmol1K1 for ΔHion  and ΔSion,  respectively. This value of ΔHion  is consistent with either a cysteine or histidine active-site residue, but not a carboxylic acid. From the plots of logkcat  versus pH for Z-RR-AMC, we in kind examined the temperature dependence of pK1 (5.3–5.5). The resulting average values (n ≥ 2) of pK1 decreased from 5.34 ± 0.06 at 25 °C to 4.92 ± 0.06 at 40 °C, and again, fitting of pK1 versus 1/T (Kelvin) was linear (Figure 3). Fitting to eq 12 resulted in ΔHion  and ΔSion  values of 7.1±0.06kcal/mol and 1015calmol1K1, respectively. The residue involved in the kcat  profile is also likely to be a basic histidine.

Affinity Labeling with Iodoacetamide and Diethyl Pyrocarbonate.

We employed affinity labeling studies of cruzain using the thiol-specific reagent, iodoacetamide. Preincubation of iodoacetamide (0–1 mM) with cruzain, followed by its dilution and analysis of residual enzymatic activity, resulted in irreversible, time-dependent inactivation. The observed first-order rate constants of inactivation, kobs , obtained from fitting of residual enzyme activity versus time (eq 2) demonstrated higher rates of inactivation with increasing concentrations of iodoacetamide (Figure 4A). The inclusion of increasing, fixed concentrations of Z-FR-AMC in the reaction mixtures ablated the inactivation, indicating that iodoacetamide reacted with catalytic Cys25 (data not shown). A replot of the first-order rate constant of inactivation, kobs, versus iodoacetamide concentration demonstrated that inactivation of cruzain by iodoacetamide was not saturable (Figure 4A), which is typical for affinity labeling agents. The second-order rate constant for inactivation, kinact/KJ, was obtained from the slopes of replots of kobs versus iodoacetamide concentration by fitting to eq 3a (Figure 4A, inset). At pH 8.0, kinact /KI=6.9±0.2M1s1.

Figure 4.

Figure 4.

(A) Representative data of the time-dependent inactivation of cruzain by iodoacetamide at pH 8.0. Lines drawn through the experimental data were from fitting to eq 2. The inset displays a replot of the inactivation rate kobs vs iodoacetamide concentration, and the line drawn through the experimental data points was obtained from fitting to eq 3a. (B) pH dependence of the second-order rate constant for cruzain inactivation by iodoacetamide (0–1 mM). The line drawn through the experimental data was obtained by fitting of the data to eq 13.

We determined the pH dependence (Ph 5.5–10.0) of cruzain inactivation by iodoacetamide (Figure 4B). The resulting plot of kinact /KI versus pH exhibited a “wave” in which the level of enzyme inactivation increased from an invariant value at neutral pH to a higher value of 180 ± 20 M−1 s−1 at pH 10. The pH dependence of the second-order rate constant of inactivation of cruzain kinact /KI by iodoacetamide can be fitted to eq 13

kinact KI=kL+kH(10(pHpKa))1+10(pHpK) (13)

where kL and kH are values of kinact /KI at low and high pH, respectively, and pKa is the acid dissociation constant for an enzymatic group. Fitting of the data indicated that deprotonation of an enzymatic group with a pKa of 9.76 ± 0.04, likely to be the thiol of active-site Cys25, resulted in the increased rate of inactivation at high pH.

Cruzain can also be inactivated by the histidine-specific affinity agent, diethyl pyrocarbonate (DEPC),38 in a time-dependent manner. At pH 7.2, preincubation of 1 nM cruzain with 1.6–104 μM DEPC for 40–340 s led to an apparent biphasic inactivation of cruzain (Figure 5A). The initial phase (t<40s) occurred too rapidly to be measured; at the shortest preincubation time of 40 s, 11–50% of cruzain was already inactivated by respective DEPC concentrations of 6.5–104 μM. The slower second phase of inactivation was observed at 40–340 s. Replotting the kobs (from fitting to eq 2) versus [DEPC] resulted in a hyperbolic plot (Figure 5B), from which fitting of these data to eq 3b provided the following values: kinact =0.23±0.02min1,KI=7±1μM, and kinact/KI=550M1s1. Cruzain is therefore exceptionally sensitive to inactivation by DEPC, especially considering the unmeasurable, rapid phase of inactivation (for comparison, kinact /KI=0.75M1s1 for phosphotriesterase39). The biphasic kinetics of DEPC inactivation suggested that either more than a single histidine had been carboethoxylated or a single histidine had been labeled on both of its nitrogens. No pH dependence of the second phase of DEPC inactivation was observed (pH 5–8) Increasing concentrations of Z-FR-AMC in preincubation mixtures containing cruzain and DEPC led to protection from inactivated by DEPC, which indicated that inactivation occurs via covalent modification of the active site of cruzain.

Figure 5.

Figure 5.

(A) Time-dependent inactivation of cruzain by 1.6–104 μM DEPC at pH 7.2. The lines drawn through the experimental data points were from fitting of the data to eq 2. (B) Replot of kobsvs [DEPC]. Fitting of the data to eq 3b results in the following values: kinact =0.23±0.02min1,KI=7±1μM, and kinact /KI=548M1s1.

Protonation States of the Catalytic Cysteine and Histidine Groups.

Cysteine proteases/hydrolases universally possess a conserved catalytic Cys-His dyad, for which the catalytic cysteine serves as a nucleophile to effect acyl transfer, while the histidine facilitates the deprotonation of the thiol of the cysteine and the lytic water and provides a proton for the amine product. The active, monoprotonated forms of cysteine proteases that exist at the maxima of bell-shaped pH−rate profiles (HE in Scheme 2) could result from two tautomeric species of the catalytic dyad: a neutral thiol-imidazole (Cys-SH/His) or an ionic thiolate-imidazolium species (Cys-S/HisH+). Bednar has measured the thiolate:thiol nucleophilicity ratio to be 1010:1.40 Polgar showed via pH−rate profiles of the inactivation of papain by haloacetamide that the pK values of the active-site cysteine (4.0) and histidine (8.4) comprised a case of “reverse protonation”,20 consistent with the sKIE studies of Creighton et al.21,22 Solvent kinetic isotope effects on kcat/Km in these studies were inverse, supporting an enrichment of the thiolate species in D2O arising from a fractionation factor for thiol of 0.45.24,36 Lewis et al. demonstrated via nuclear magnetic resonance studies of papain that the imidazoliumthiolate form was the predominant species in the unbound enzyme.23 In kind, detailed sKIE studies of human cathepsin C were consistent with that of papain; that is, the thiolateimidazolium species of the free enzyme predominates in catalysis: D2Okcat /Km=0.71,D2Okcat =2.76,pKa(CysSH)=4.3, and pKb(His)=6.5.

In contrast, the pH−rate profiles of kcat /Km for all three cruzain substrates were characterized by essential unprotonated and protonated catalytic groups with pK1=6.26.6 and pK2=9.8, respectively, consistent with neutral forms of the His and Cys species at the pH optimum of cruzain. Other studies described herein confirm the assignment of these pKs. (a) Mutagenic replacement of Glu208 does not eliminate cruzain activity or the pK1 observed in the pH−rate profile of Z-RR-AMC. (b) Values of ΔHion  obtained from temperature variation studies for a pK1 of 6.2 are in agreement with that of a histidine group. (c) The pH dependence of inactivation of cruzain by the thiol-specific agent iodoacetamide increased upon deprotonation of a residue with a pKa of 9.76 ± 0.04. (d) An absence of an inverse sKIE on kcat/Km indicates that Cys25 is protonated in the free enzyme. (e) For Z-RR-AMC and Z-RA-AMC, the ΔpK1 of 0.5–0.8 is consistent with a histidine group, but not a cysteine.35,36 Also, from the temperature dependence of a pK1 of 5.3 from logkcat  vs pH, the obtained value of ΔHion  was also consistent with the involvement of a basic histidine despite the low value of its pK. This pK1 value of 5.3, for which cruzain is saturated with substrate, is identical to the pK value of 5.2–5.3 for His162 obtained from nuclear magnetic resonance analysis of cruzain covalently complexed to dipeptide analogue K11777.26

The finding of a neutral Cys-His catalytic dyad for free cruzain has several implications. In free cruzain, it is likely that the respective sulfur and nitrogen atoms of Cys25 and His162 are not sufficiently proximal to allow the formation of the thiolateimidazolium dyad seen in papain and cathepsin C. In addition, the neutral Cys-His dyad of cruzain would be a far poorer catalyst for hydrolysis than the thiolate-imidazolium dyad, and removal of the proton from Cys25 would be required upon substrate binding. As stated above, USP1 hydrolase also possesses a neutral Cys-His dyad for which proton transfer apparently occurs upon binding of the large ubiquitinated protein substrate.25 In the cases of the cysteine hydrolases dimethylarginine dimethylaminohydrolase (DDAH)41 and protein arginine deiminases 2 (PAD2),42 it was similarly proposed that the binding of the positively charged substrates facilitates catalysis by depressing the pKa of the catalytic cysteine to facilitate its deprotonation. Close examination of the crystal structure of PAD2 revealed that Cys645 and His471 are further separated than the catalytic dyad is in PAD4, a closely related isozyme found to have the thiolate form of the activesite cysteine irrespective of substrate binding. Cruzain may be a member of an apparent subclass of cysteine hydrolases that, possibly because of active-site geometry, has a neutral Cys-His dyad in their ligand-free forms that requires substrate binding to assist proton transfer from His to Cys, as suggested for USP1.25

Pre-Steady-State Kinetics and Solvent Isotope Effects.

Pre-steady-state kinetics for the cruzain-catalyzed hydrolysis of Z-FR-AMC and Z-RR-AMC in both H2O and D2O were generated at pH(D) 7.5 in a stopped-low fluorimeter by measurement of product AMC. While solvent kinetic isotope effects should be determined over a range of pH(D) values to eliminate the possibility that observed sKIEs are due to the equilibrium isotope effects that perturb pK values of active-site residues, the lack of pH(D) dependence of either substrate between pH(D) 7.0 and 8.0 allows us to assess the sKIEs at pH(D) 7.5. For each substrate concentration in either solvent, all time courses exhibited an initial, rapid burst of AMC, followed by a linear, steady-state rate of AMC product formation (Figure 6, Figure S4, and Table 3). Burst amplitudes increased with increasing fixed concentrations of substrates to apparent saturation. In contrast, no transient burst was observed for Z-RA-AMC. These results are very similar to those of cathepsin C, in which dipeptide-AMC substrates with high kcat /Km values are characterized by a burst phase in which the transient:steady-state rate ratio was ~ 20:1, while poor substrates displayed no transient bursts.24,43 In these previous studies, the rate constant of the transient phase (λ) could be attributed to the acylation half-reaction kac that encompasses the catalytic steps described by kcat /Km, while the steady-state rate constant kcat  was equivalent to the rate constant of the deacylation half-reaction kdac. Likewise, for Z-FR-AMC and Z-RR-AMC, the observed transient rates demonstrated that the rate of transfer of an acyl group to cruzain exceeded the steadystate rate of deacylation, while for the poor substrate Z-RA-AMC, kac and kdac are comparable, for which no pre-steady-state burst would be observed. For the pre-steady-state kinetics of Z-FR-AMC (Figure 6) and Z-RR-AMC (Figure S4) performed in D2O, transient bursts were also observed, albeit with slower transient and steady-state rates (data for the substrate Z-RR-AMC are found in the Supporting Information).

Figure 6.

Figure 6.

Pre-steady-state time courses of cruzain-catalyzed hydrolysis of Z-FR-AMC [0.5 (red), 1.0, 1.5, 2.0, 2.5, 3.0, 3.75, 5.0. 6.25, 7.5, and 8.75 (black) μM] in H2O and D2O at 0.002–0.1 s, with the product formation shown on the same scale. The black lines drawn through the experimental data represent fitting to eq 11.

Table 3.

Pre-Steady-State Kinetic Parameters of Cruzain-Catalyzed Hydrolysis of Z-FR-AMC and Z-RR-AMC in H2O and D2Oa

substrate solvent kcat(s1) b kac(s1) kdac(s1) Ka(μM) Kia(μM) c
Z-FR-AMC H2O 30.5 ± 0.1 239 ± 6 35 ± 1 2.3 ± 0.1 9.8 ± 0.6
D2O 14.7 ± 0.1 179 ± 2 16 ± 1 0.86 ± 0.01 9.0 ± 0.7
sKIEd D2Okcat =2.07±0.02 D2Okac=1.34±0.01 D2Okdac=2.2±0.2 D2OKa=2.7±0.1 D2OKia=1.09±0.11
Z-RR-AMC H2O 15.2 ± 0.1 64.5 ± 0.2 19.9 ± 0.1 7.0 ± 0.1 14.0 ± 3.0
D2O 9.5 ± 0.1 46.1 ± 0.1 11.9 ± 0.1 5.5 ± 0.1 15.0 ± 3.0
sKIEd D2Okcat =1.61±0.02 D2Okac=1.40±0.01 D2Okdac=1.67±0.02 D2OKa=1.27±0.03 D2OKia=0.93±0.27
a

Data were obtained as described in Experimental Procedures at pH(D) 7.5 in 10% (v/v) DMSO. The kinetic parameters were determined from global fitting according to eq 11.

b

kcat was calculated from kac and kdac, and values of Kia in H2O and D2O for both substrates were determined separately as described. The errors for all the kinetic parameters are the standard deviations determined from the nonlinear least-squares fitting of the data.

c

Determined from fitting the transient burst rate vs substrate concentration according to eq 11.

d

Solvent kinetic isotope effects as determined from the ratio of the two sets of kinetic parameters in H2O and D2O. The errors were calculated on the basis of the propagation of fractional errors.

For both substrates, the time courses obtained at each fixed concentration of substrate in either solvent were best fitted to a single-exponential function at all concentrations (eq 8), and values for the resulting steady-state rate constant vss, burst amplitude (β), and transient rate constant (λ) were replotted separately versus substrate concentration and fitted to eqs 1,9, or 10 (Figure 7 and Figure S5). For both solvents, we determined the transient rate constant λ over a larger range of fixed concentrations of both substrates (≤80 μM) to observe saturation (Figure 7C). The steady-state rate is diminished in D2O, but more so at higher concentrations of Z-FR-AMC in agreement with kinetics obtained in the steady state (Figure 7A; D2Okcat =2.3 from fitting to eq 1), as expected, because the steady-state sKIE is larger on kcat  than on kcat /Km. Interestingly, the apparent effect of D2O on the burst amplitude is to make it larger than that observed in H2O, which is due to the large differences in fitted values of Ka. Replotting of the transient rate constant (λ) versus [Z-FR-AMC] provided the following values upon fitting to eq 10: kac=233s1 and D2Okac=1.4. The latter value is identical to that which is obtained for the substrate Ser-Tyr-AMC with human cathepsin C.24

Figure 7.

Figure 7.

Replots of the kinetic parameters obtained from fitting individual time courses at each substrate concentration to eqs 810 in H2O (blue) and D2O (red). Substrate concentrations used to determine the transient rate constants were 1.5–79 μM, compared to substrate concentrations used for the steady-state rate and burst amplitudes (0.5–8.75 μM). (a) Fitting of the steady-state rate vs [Z-FR-AMC] (eq 1) resulted in the following values: kcat=34.2±1.9s1 and Ka=3.9±0.5μM in H2O, and kcat =14.6±0.3s1 and Ka=1.4±0.1μM in D2O. (b) Fitting of the burst amplitude vs [Z-FR-AMC] (eq 9) resulted in the following values: kcat =34s1,Ka=1.1±0.1μM, and kdac=36.5±0.8s1H2O, and kcat=14.6s1,Ka=0.6±0.06μM, and kdac=14.4±0.2s1D2O. (c) Fitting of the transient rate constant vs [Z-FR-AMC] (eq 10) resulted in the following values: kac=233±3s1,kdac=12±3s1, and Kia=9.8±0.6μMH2O, and kac=167±3s1,kdac=14±3s1, and Kia=9.0±0.7μMD2O.

Kinetic parameters for Z-FR-AMC and Z-RR-AMC, including sKIEs on kcat,kac, and kdac as obtained from global fitting using eq 11 of pre-steady-state data are listed in Table 3. This full set of kinetic parameters was well-determined, as opposed to those obtained from replots as depicted in Figure 7. For Z-FR-AMC, the rate constant of cruzain acylation kac=239±6s1 was 8-fold higher than the turnover number kcat=30±0.1s1 and the equivalent rate constant of deacylation kdac=35±1s1. For Z-RR-AMC, these rate constants were lower: kac=64.5±0.2s1, which was 4-fold higher than the turnover number kcat=15.2±0.1s1 and its similar rate constant of deacylation kdac=19.9±0.1s1. The normal sKIEs for kcat  for the two substrates [D2Okcat =2.07±0.02 (Z-FR-AMC), and D2Okcat =1.61±0.02 (Z-RR-AMC)] are comparable to the pL-independent values obtained in the steady-state studies. For both substrates, normal sKIEs were obtained for the rate constants of acylation and deacylation: D2Okac=1.34±0.04 and D2Okdac =2.2±0.2 (Z-FR-AMC), and D2Okac=1.40±0.01 and D2Okdac=1.67±0.02 (Z-RR-AMC). The fact that D2Okcat ~D2Okdac  for both substrates provides further evidence that the rate constants of enzyme deacylation determine the turnover numbers. We attribute the differences in measured values of kcat  and Km under steady-state and presteady-state conditions to the increased concentration of DMSO in the latter experiments, as borne out by additional studies in the steady state where these parameters were obtained in both 2% (v/v) and 10% (v/v) DMSO (data not shown).

Catalytic Mechanism of Cruzain.

Similar to the mechanism of human cathepsin C, the acylation half-reaction of cruzain is significantly faster than deacylation for those substrates with the highest values of kcat /Km.43 Where the two enzymes differ is that for cruzain, all solvent kinetic isotope effects are normal, indicating no enrichment of the Cys-S:His-H+ tautomer of the ligand-free enzyme species in D2O, so the Cys-His catalytic dyad is neutral at the initiation of catalysis. Accordingly, we may consider two catalytic mechanisms for cruzain for which Cys25-SH and His162 are both neutral in free enzyme E (Figure 8). Binding of substrate to form EA facilitates proton transfer from Cys25 to His162, at which point the two mechanisms diverge. In mechanism 1 (Figure 8, green box), conformational isomerization of complex EA to EA’ positions Cys25,His162, and the substrate for a concerted reaction of general base-catalyzed proton transfer and attack of the incipient thiolate of Cys25 on the scissile amide carbonyl. In mechanism 2 (Figure 8, magenta box), thiolation of the amide carbonyl occurs in two discrete steps. (1) General basecatalyzed proton transfer to His162 establishes the imidazoliumthiolate dyad EA+/−, and (2) the resulting thiolate attacks the amide carbonyl to form tetrahedral intermediate EX. One expects that the equilibrium isotope effect (EIE) for the formation of the thiolate in EA+/− from EA would be inverse (DKeq3=0.45 as in the case of cathepsin C),24 which could allow discrimination of these two mechanisms. The acylation half-reaction is then completed upon the collapse of the EX intermediate with proton transfer from the imidazolium group to the departing AMC, which completes the transient phase seen in pre-steady-state kinetics. Discrimination of these two potential mechanisms is discussed below. The slower, deacylation half-reaction kcat~kdac is the same for both mechanisms: Neutral His162 in the F complex deprotonates the lytic water leading to the second tetrahedral intermediate, FX, which then collapses to elaborate the carboxylate product and restores Cys25 and His162 to their neutral forms.

Figure 8.

Figure 8.

Proposed catalytic mechanisms for cruzain each involving acylation and deacylation half-reactions. Ligand-free cruzain contains neutral forms of Cys25(pK~9.8) and His162(pK~6.6) that are not positioned for proton transfer until substrate is bound. In mechanism 1 (green box), proton transfer from Cys25 to His162 is concerted with thiolate attack on the amide carbonyl to form tetrahedral intermediate EX. This occurs in two discrete steps in mechanism 2 (magenta box) in which the thiolate of Cys25 attacks the amide. Steps in the deacylation half-reaction are the same for both mechanisms: thio-ester form F undergoes attack by a hydroxide ion to form a second tetrahedral intermediate FX, which collapses to form the carboxylate product. Protons involved in primary solvent kinetic isotope effects are colored red. Free AMC is colored light green where it is expected to show full fluorescence.

Estimation of the Individual Kinetic Constants and Intrinsic Isotope Effects.

We sought to discriminate between the two proposed catalytic mechanisms by ascertaining values of the individual rate constants and intrinsic isotope effects on the catalytic steps. Expressions for the eight experimental kinetic parameters were derived in the steady state by the method of net rate constants for both mechanisms (eqs 1421), for which ae,x, and y represent commitment factors.44 Equations 18a and 20a are for mechanism 1, and eqs 18b and 20b are for mechanism 2.

a=k3/k2,b=k5/k4,c=k6/k7,d=k5/k7,e=k7/k9,x=k13/k12,y=k13/k15,Keq3=k3/k4,Keq11=k11/k12
kcat/Ka=(k5Keq3)/{Kia[1+b(1+a)+c]} (14)
kcat=kackdac/kac+kdac (15)
kac=k5Keq3/1+b+c+Keq3[1+c+d(1+e)] (16)
kdac=k13Keq11/1+x+Keq11(1+y) (17)
D2Okcat/Ka=Dk5+b(1+a)+cDk7DKeq5/[1+b(1+a)+c] (18a)
D2O(kcat/Ka)=[DKeq3+b(Dk3+a)+cDk7DKeq3]/[1+b(1+a)+c] (18b)
D2Okcat=Dkdackac+Dkackdac/kac+kdac (19)
D2Okac=[1+Keq3Dk5+cDk7DKeq5+b+Keq3dDk7+e]1+b+c+Keq3[1+c+d(1+e)] (20a)
D2Okac=[DKeq3(Dk7c+1)+Dk3b+Keq3(1+cDk7+d(Dk7+e)][(1+b+c+Keq3(1+c+d(1+e)] (20b)
D2Okdac=[Dk13DKeq11+xDk11+Keq11(Dk13+y)]/[1+x+Keq11(1+y)] (21)

To generate estimates of microscopic rate constants and intrinsic isotope effects (Dk3, etc.) found in the eight measured kinetic parameters (eqs 1421) acquired for cruzain under presteady-state and steady-state conditions (Tables 2 and 3), we utilized the dynamic simulation capability of Kintek Explorer45 to iteratively search for and optimize values of k1k15 for the two mechanisms in Figure 8 until we generated simulated time courses that superimposed with the experimental data in H2O for both Z-RR-AMC and Z-FR-AMC. We conducted a similar simulation for the time courses performed in D2O, and the intrinsic kinetic isotope effects for each catalytic step Dk1Dk15 were then calculated by dividing each individual rate constant obtained in H2O by its counterpart obtained in D2O; for example, Dk3=k3H2O/k3D2O. The simulated time courses generated from these “candidate” rate constants are in good agreement with the experimental time courses for both Z-FR-AMC and Z-RR-AMC in H2O as shown in Figure 9. By calculating the corresponding rate constants k1k15 in D2O by division of each rate constant by its intrinsic isotope effect kxD2O=kxH2O/Dkx, we likewise obtained simulated time courses that can be superimposed on the experimental ones obtained in D2O (Figure 9). The rate constants k1k15 and intrinsic kinetic isotope effects Dk1,Dk3,Dk7,Dk11, and Dk13 in Table 4 comprise reasonable values for mechanism 2. To differentiate between mechanisms 1 and 2 in Figure 8, we reinserted the determined intrinsic values and individual rate constants into eqs 1421 for both mechanisms 1 and 2 and calculated values for the eight kinetic parameters (Table 4, calculated kinetic parameters). The calculated kinetic parameters listed in Table 4 are for mechanism 2, where eqs 18b and 20b were used.

Figure 9.

Figure 9.

Experimental pre-steady-state time courses of cruzaincatalyzed hydrolysis of 8.75 μM Z-FR-AMC and 30 μM Z-RR-AMC in H2O (blue) and D2O (red) from data found in Figure 6 and Figure S4. The white lines drawn through all curves were produced by dynamic simulation using Kintek Explorer; here the enzyme species EX, FP, and P (P = AMC) and product carboxylic acid were assigned as the observables (generation of a fluorescence signal). For each experimental time course, values of rate constants k1k15 were iteratively selected until the simulated curve could be superimposed upon the experimental time course for both substrates, as shown here. The rate constants from this approach led to the “candidate values” listed in Table 4. Values of the intrinsic isotope effects in Table 4 were obtained by dividing each individual rate constant optimized in H2O by that optimized in D2O; for example, Dk3=k3H2O/k3D2O. The four simulated curves were generated with Z-RR-AMC and Z-FR-AMC: k1 = 50 and 75μM1s1,k2=700 and 730s1,k3=70 and 400s1,k4= 300 and 400s1,k5=800 and 1100s1,k7=6000s1,k9=8000s1,k11=280 and 300s1,k12=430 and 700s1,k13=27 and 60s1,k15= 1500s1,Dk1=1.1,Dk3=1.4,Dk7=1.2 and 1.4,Dk11=1.2 and 1.6, and Dk13=1.4 and 1.9.

Table 4.

Experimental and Calculated Kinetic Parameters for the Catalytic Mechanism of Cruzain.a

Substrate Cbz-Arg-Arg-AMC Cbz-Phe-Arg-AMC
Kinetic Parameter Experimental Value Calculated Value Candidate Value Experimental Value Calculated Value Candidate Value
kcat/Ka 1.9±0.2 μM1s1 4 μM1s1 Dk1=1.1 27±4 μM1s1 25 μM1s1 Dk1=1.1
Kia 14±3 μM 14 μM Dk3 or Dk5=1.4 9.8±0.6 μM 9.8 μM Dk3 or Dk5=1.4
D2O(kcat/Ka) 1.15 ± 0.08 1.14 Dk7=1.2 1.4 ± 0.1 1.4 Dk7=1.3
kac 64.5± 0.2 s−1 65 s−1 Dk11=1.2 239 ± 6 s−1 239 s−1 Dk11=1.6
D2Okac 1.41 ± 0.01 1.2 Dk13=1.4 1.34 ± 0.01 1.2 Dk13=1.9
kdac 19.9 ± 0.1 s−1 20 s−1 a=k3/k2=0.14 35 ± 1 s−1 35 s−1 a=k3/k2=0.5
D2Okdac 1.67± 0.02 1.6 b=k5/k4=2.6 2.2 ± 0.02 2.3 b=k5/k4=5.0
kcat 15.2 ± 0.1 s−1 15 s−1 c=k6/k7=0 30 ± 1 s−1 30 s−1 c=k6/k7=0.0002
D2Okcat 1.61 ± 0.02 1.5 d=k5/k7=0.13 2.07 ± 0.02 2.08 d=k5/k7=0.18
Ka 7.0±0.1 μM 4 e=k7/k9=0.8 2.3±0.1 μM 1.2 e=k7/k9=0.8
tKIE° 1.6 1.8 x=k13/k12=0.18 2.2 2.1 x=k13/k12=0.1
Sr 4 4 y=k13/k15=0.02 70 ± 50 9 y=k13/k15=0.015
k1=50 μM1s1 k1=75 μM1s1
k2=700s1 k2=735s1
k3=100s1 k3=400s1
k4=300s1 k4=220s1
k5=800s1 k5=1100s1
k6=0s1 k6=1s1
k7=6000s1 k7=6000s1
k9=8000s1 k9=8000s1
k11=280s1 k11=300s1
k12=430s1 k12=700s1
k13=55s1 k13=135s1
k15=5000s1 k15=5000s1
a

Experimental kinetic parameters are those reported in Tables 2 and 3. Solvent equilibrium isotope effects, DKeq =0.60.7, and DKeq11 =1.3, intrinsic isotope effects on each step Dk115, and microscopic rate constants k115 were obtained by dynamic simulation of the experimental pre-steady-state kinetic data using Kintek Explorer.47 Candidate values obtained from these fittings were then inserted into eqs 1421 to produce the calculated values in the table. Values for k3 and k13 presented here resulted from extrapolation to an infinite concentration of the variable substrates to produce limiting values kcat,kac, and kdac.

From this and for both substrates, the “candidate” microscopic rate constants were more in accord with mechanism 2 than mechanism 1. Experimental and calculated values for both substrates (mechanism 2) agreed within a variation of ≤ 10%, except for kcat /Km for Z-RR-AMC, indicating that otherwise these candidate values, while not necessarily unique, are reasonable. By calculating kinetic parameters for both substrates for mechanism 1 using the values listed in Table 4 (eqs 18a and 20a; Dk5=1.4) we obtained D2Okcat/Km=1.3 and D2Okac=1.4, which exhibited poorer agreement with experimental results than with the kinetic parameters calculated for mechanism 2. One would expect the conformational change in the k3 step of mechanism 1 to be faster than the subsequent chemical k5 step and to exhibit no solvent KIE. For Z-FR-AMC under mechanism 2, proton transfer in the k3 step is 4 times faster than that of Z-RR-AMC k3=400s1 compared to k3=100s1), suggesting that the Cbz-Phe-Arg dipeptide scaffold is more favorable for initiating proton transfer from Cys25 to His162 than Cbz-Arg-Arg is, and this difference in rate constants accounts for the 4-fold difference observed for kac. The stickiness of Z-FR-AMC is reflected in the calculated k5/k41+k3/k2 ratio of 9, while it is lower than the value determined from the plot of logkcat/Km versus pH. This indicates that upon binding of Z-FR-AMC and proton transfer from Cys25 to His162, the enzyme–substrate complex EA +/− is highly committed to further catalytic steps k5/k4=5, and accordingly, the subsequent attack by the resulting thiolate on the substrate carbonyl carbon to form EX is rapid k5=1100s1). Collapse of tetrahedral intermediate EX to form the enzyme–dipeptide thioester FP is very rapid k7=6000s1 with a modest intrinsic isotope effect on te proton transfer from His162 to the departing amine (AMC) Dk7=1.21.3.

For Z-RR-AMC, the catalytic steps for k1k7 are unsurprisingly slower than those of Z-FR-AMC, possibly because of a favorable ionic interaction of the Arg group at P2 with Glu208, while Z-RR-AMC has a lower stickiness ratio k5/k41+k3/k2 of 4. As with Z-FR-AMC, the k3 step (100 s−1) is the slowest in the acylation half-reaction, and the intrinsic KIE of Dk3=1.4 accounts for D2Okac. The k5k9 steps are similar, if not identical, in rate to that of Z-FR-AMC. From the simulation, for both substrates, calculated values for DKeq3 of 0.6–0.7 (deprotonation of cysteine) and for DKeq11 of 1.3 (hydroxide attack on the thioester) were obtained, where the former value DKeq 3=Dk3/Dk4 is inverse because Dk4>Dk3. These equilibrium isotope effects compare favorably with values calculated from fractionation factors DKeq3=0.45 and DKeq11=1.30,36

In the deacylation half-reaction, the determined rate constants indicated that the rates of formation of the tetrahedral complex for both substrates in FX k11=280 and 300s1) are similar, followed by rate-determining collapse of this intermediate to form the cruzain−carboxylate (EQ) complex (k13=55 and 135s1), for which the intrinsic kinetic isotope effects of Dk13=1.4 and 1.9 for Z-RR-AMC and Z-FR-AMC, respectively, account for the measured values of D2Okdac and D2Okcat .

CONCLUSIONS

Similar to human cathepsin C, the most efficient substrates of cruzain undergo rapid acylation, which precedes rate-limiting deacylation. However, cruzain differs from papain, cathepsin C, and other cysteine proteases, in that its ligand-free form houses the less reactive, neutral Cys-SH/His dyad, implicit in both its pH–rate profiles and sKIEs of >1. This neutral dyad apparently undergoes proton transfer from the thiol of Cys25 only upon substrate binding, which most likely occurs in a stepwise fashion (mechanism 2). That general base deprotonation of Cys25SH by His162 elaborates the fact that the reactive thiolate comprises unusual chemistry for cruzain catalysis. Leinhard and Jencks demonstrated more than 50 years ago that general base deprotonation of thiols was not a feature of their reactions with the carbonyl groups of aldehydes and ketones but rather the thiolate fraction present was the sole reactant.46 Why then would unliganded cruzain adopt the unreactive Cys-SH:His tautomer and rely on this general base catalytic step to unmask the catalytic Cys-S:HisH+ upon substrate binding? One is tempted to speculate that this is a feature of stringent substrate specificity in that only those bound substrates that affect the proton transfer step (k3 of mechanism 2) proceed to peptidolysis.

The rate-limiting steps for these two substrates occur during deacylation of these substrates exhibiting normal sKIEs. The less efficient substrate Z-RA-AMC is devoid of a pre-steadystate burst, suggesting that its diminished ability to induce this proton transfer renders kac~kdac. In terms of the future design of peptidomimetic covalent inactivators of cruzain such as K11777, the choice of amino acid residues at the P1 and P2 residues may determine whether the dipeptide “scaffold” binds in a fashion that promotes the transfer of the proton on Cys25-SH to His162 to elaborate the more nucleophilic Cys25 thiolate species, which would then progress to alkylation of the activesite catalytic cysteine by its vinyl sulfone warhead. Our results suggest that a peptidomimetic inactivator bearing a Phe-Arg dipeptide may be more favorable than that with an Arg-Arg or Arg-Ala dipeptide.

Supplementary Material

zhai and meek SI

ACKNOWLEDGMENTS

The authors thank Professor Charles S. Craik for providing a construct for the expression of cruzain and Dr. Larry Dangott for providing protein sequencing. The authors also thank Professor Ken Johnson for assistance with the use of Kintek Explorer.

Funding

The authors thank Texas A&M AgriLife Research for financial support of this work. This work was also supported by National Institutes of Health Grant R21AI127634.

ABBREVIATIONS

MMTS

methylmethanethiosulfonate

DEPC

diethylpyrocarbonate

DTT

dithiothreitol

DMSO

dimethyl sulfoxide

AMC

7-amino-4-methylcoumarin

Z-FR-AMC

carboxybenzyl-L-phenylalanine-L-arginine-7-amino-4-methylcoumarin

Z-RR-AMC

carboxybenzyl-L-arginine-L-arginine-7-amino-4-methylcoumarin

Z-RA-AMC

carboxybenzyl-L-arginine-L-alanine-7-amino-4-methylcoumarin

EDTA

ethylenediaminetetraacetic acid

CHAPS

3-[3-(cholamidopropyl)dimethylammonio]-1-propanesulfonate

TAPSO

3-{[1,3-dihydroxy-2-(hydroxymethyl)-propan-2-yl] amino}-2-hydroxypropane-1-sulfonic acid

MES

2-(N-morpholino)ethanesulfonic acid

TEA

triethanolamine

DEA

diethanolamine

sKIE

solvent kinetic isotope effect

Footnotes

Supporting Information

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.biochem.7b01250.

Steady-state kinetic data for wild-type cruzain-catalyzed reactions of Z-FR-AMC, Z-RR-AMC, and Z-RA-AMC in H2O and D2O and E208A mutant cruzain-catalyzed reactions of Z-FR-AMC, Z-RR-AMC, and Z-RA-AMC in H2O;pK values of E208A cruzain; pH−rate profiles of the E208A mutant-catalyzed reactions of Z-FR-AMC, Z-RR-AMC, and Z-RA-AMC in H2O; and pre-steady-state data and replots of pre-steady-state kinetic constants for the wild-type cruzain-catalyzed reaction of Z-RR-AMC in H2O and D2O (PDF)

The authors declare no competing financial interest.

REFERENCES

  • (1).Coura JR, and Vinas PA (2010) Chagas disease: a new worldwide challenge. Nature 465, S6–S7. [DOI] [PubMed] [Google Scholar]
  • (2).Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, and Periago MR (2008) The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Neglected Trop. Dis 2, e300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (3).Wilkinson SR, and Kelly JM (2009) Trypanocidal drugs: mechanisms, resistance and new targets. Expert Rev. Mol. Med 11, e31. [DOI] [PubMed] [Google Scholar]
  • (4).Meirelles MN, Juliano L, Carmona E, Silva SG, Costa EM, Murta AC, and Scharfstein J (1992) Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol. Biochem. Parasitol 52, 175–184. [DOI] [PubMed] [Google Scholar]
  • (5).Harth G, Andrews N, Mills AA, Engel JC, Smith R, and McKerrow JH (1993) Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi. Mol. Biochem. Parasitol 58, 17–24. [DOI] [PubMed] [Google Scholar]
  • (6).Engel JC, Doyle PS, Hsieh I, and McKerrow JH (1998) Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med 188, 725–734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Doyle PS, Zhou YM, Engel JC, and McKerrow JH (2007) A cysteine protease inhibitor cures Chagas’ disease in an immunodeficient-mouse model of infection,. Antimicrob. Agents Chemother 51, 3932–3939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).Doyle PS, Zhou YM, Hsieh I, Greenbaum DC, McKerrow JH, and Engel JC (2011) The Trypanosoma cruzi protease cruzain mediates immune evasion,. PLoS Pathog. 7, e1002139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (9).Ferrao PM, d’Avila-Levy CM, Araujo-Jorge TC, Degrave WM, Gonçalves A. d. S., Garzoni LR, Lima AP, Feige JJ, Bailly S, Mendonca-Lima L, and Waghabi MC (2015) Cruzipain Activates Latent TGF-beta from Host Cells during T. cruzi Invasion. PLoS One 10, e0124832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).Martinez-Mayorga K, Byler KG, Ramirez-Hernandez AI, and Terrazas-Alvares DE (2015) Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits. Drug Discovery Today 20, 890–898. [DOI] [PubMed] [Google Scholar]
  • (11).Kerr ID, Lee JH, Farady CJ, Marion R, Rickert M, Sajid M, Pandey KC, Caffrey CR, Legac J, Hansell E, McKerrow JH, Craik CS, Rosenthal PJ, and Brinen LS (2009) Vinyl sulfones as antiparasitic agents and a structural basis for drug design. J. Biol. Chem 284, 25697–25703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (12).Barr SC, Warner KL, Kornreic BG, Piscitelli J, Wolfe A, Benet L, and McKerrow JH (2005) A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi. Antimicrob. Agents Chemother 49, 5160–5161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (13).Lecaille F, Kaleta J, and Bromme D (2002) Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem. Rev 102,4459–4488. [DOI] [PubMed] [Google Scholar]
  • (14).Choe Y, Leonetti F, Greenbaum DC, Lecaille F, Bogyo M, Bromme D, Ellman JA, and Craik CS (2006) Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J. Biol. Chem 281, 1282412832. [DOI] [PubMed] [Google Scholar]
  • (15).Storer AC, and Menard R (1994) Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol. 244, 486–500. [DOI] [PubMed] [Google Scholar]
  • (16).Shokhen M, Khazanov N, and Albeck A (2009) Challenging a paradigm: theoretical calculations of the protonation state of the Cys25-His 159 catalytic diad in free papain. Proteins: Struct., Funct., Genet 77, 916–926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).Solowiej J, Thomson JA, Ryan K, Luo C, He M, Lou J, and Murray BW (2008) Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for catalysis. Biochemistry 47, 2617–2630. [DOI] [PubMed] [Google Scholar]
  • (18).Paasche A, Zipper A, Schafer S, Ziebuhr J, Schirmeister T, and Engels B (2014) Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease. Biochemistry 53, 5930–5946. [DOI] [PubMed] [Google Scholar]
  • (19).Arafet K, Ferrer S, and Moliner V (2017) Computational Study of the Catalytic Mechanism of the Cruzain Cysteine Protease. ACS Catal. 7, 1207–1215. [Google Scholar]
  • (20).Polgar L (1974) Mercaptide-imidazolium ion-pair: the reactive nucleophile in papain catalysis. FEBS Lett. 47, 15–18. [DOI] [PubMed] [Google Scholar]
  • (21).Creighton DJ, Gessouroun MS, and Heapes JM (1980) Is the thiolate−imidazolium ion pair the catalytically important form of papain? FEBS Lett. 110, 319–322. [DOI] [PubMed] [Google Scholar]
  • (22).Creighton DJ, and Schamp DJ (1980) Solvent isotope effects on tautomerization equilibria of papain and model thiolamines. FEBS Lett. 110, 313–318. [DOI] [PubMed] [Google Scholar]
  • (23).Lewis SD, Johnson FA, and Shafer JA (1976) Potentiometric determination of ionizations at the active site of papain. Biochemistry 15, 5009–5017. [DOI] [PubMed] [Google Scholar]
  • (24).Schneck JL, Villa JP, McDevitt P, McQueney MS, Thrall SH, and Meek TD (2008) Chemical mechanism of a cysteine protease, cathepsin C, as revealed by integration of both steady-state and pre-steady-state solvent kinetic isotope effects. Biochemistry 47, 8697–8710 [DOI] [PubMed] [Google Scholar]
  • (25).Villamil MA, Chen J, Liang Q, and Zhuang Z (2012) A noncanonical cysteine protease USP1 is activated through active site modulation by USP1-associated factor 1,. Biochemistry 51, 2829–2839. [DOI] [PubMed] [Google Scholar]
  • (26).Lee GM, Balouch E, Goetz DH, Lazic A, McKerrow JH, and Craik CS (2012) Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy. Biochemistry 51, 10087–10098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (27).Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, and Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. Proteomics Protocols Handbook, 571–607. [Google Scholar]
  • (28).Ellis KJ, and Morrison JF (1982) Buffers of constant ionic strength for studying pH-dependent processes. Methods Enzymol. 87, 405–426. [DOI] [PubMed] [Google Scholar]
  • (29).Schowen KB, and Schowen RL (1982) Solvent isotope effects of enzyme systems. Methods Enzymol. 87, 551–606. [PubMed] [Google Scholar]
  • (30).Cleland WW (1977) Determining the chemical mechanisms of enzyme-catalyzed reactions by kinetic studies. Adv. Enzymol. Relat. Areas Mol. Biol 45, 273–387. [DOI] [PubMed] [Google Scholar]
  • (31).Cook PF, and Cleland WW (1981) Mechanistic deductions from isotope effects in multireactant enzyme mechanisms. Biochemistry 20, 1790–1796 [DOI] [PubMed] [Google Scholar]
  • (32).Northrop DB (1981) The expression of isotope effects on enzyme-catalyzed reactions,. Annu. Rev. Biochem 50, 103–131. [DOI] [PubMed] [Google Scholar]
  • (33).Schechter I, and Berger A (1967) On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun 27, 157–162. [DOI] [PubMed] [Google Scholar]
  • (34).Gillmor SA, Craik CS, and Fletterick RJ (1997) Structural determinants of specificity in the cysteine protease cruzain. Protein Sci. 6, 1603–1611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (35).Cleland WW (1982) The use of pH studies to determine chemical mechanisms of enzyme-catalyzed reactions,. Methods Enzymol. 87, 390–405. [DOI] [PubMed] [Google Scholar]
  • (36).Quinn DM, and Sutton LD (1991) Theoretical basis and mechanistic utility of solvent isotope effects. In Enzyme Mechanism from Isotope Effects (Cook PF, Ed.) p 73, CRC Press, Inc., Boca Raton, FL. [Google Scholar]
  • (37).Karsten WE, Lai C-J, and Cook PF (1995) Inverse solvent isotope effects in the NAD-malic enzyme reaction are the result of the viscosity difference between D2O and H2O: implications for solvent isotope effect studies. J. Am. Chem. Soc 117, 5914–5918. [Google Scholar]
  • (38).Miles EW (1977) Modification of histidyl residues in proteins by diethylpyrocarbonate. Methods Enzymol. 47, 431–442. [DOI] [PubMed] [Google Scholar]
  • (39).Dumas DP, and Raushel FM (1990) Chemical and kinetic evidence for an essential histidine in the phosphotriesterase from Pseudomonas diminuta. J. Biol. Chem 265, 21498–21503. [PubMed] [Google Scholar]
  • (40).Bednar RA (1990) Reactivity and pH dependence of thiol conjugation to N-ethylmaleimide: detection of a conformational change in chalcone isomerase. Biochemistry 29, 3684–3690. [DOI] [PubMed] [Google Scholar]
  • (41).Stone EM, Costello AL, Tierney DL, and Fast W (2006) Substrate-assisted cysteine deprotonation in the mechanism of dimethylargininase (DDAH) from Pseudomonas aeruginosa. Biochemistry 45, 5618–5630. [DOI] [PubMed] [Google Scholar]
  • (42).Dreyton CJ, Knuckley B, Jones JE, Lewallen DM, and Thompson PR (2014) Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanism. Biochemistry 53, 4426–4433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (43).Rubach JK, Cui G, Schneck JL, Taylor AN, Zhao B, Smallwood A, Nevins N, Wisnoski D, Thrall SH, and Meek TD (2012) The amino-acid substituents of dipeptide substrates of cathepsin C can determine the rate-limiting steps of catalysis,. Biochemistry 51, 7551–7568. [DOI] [PubMed] [Google Scholar]
  • (44).Cleland WW (1975) Partition analysis and concept of net rate constants as tools in enzyme kinetics. Biochemistry 14, 3220–3224. [DOI] [PubMed] [Google Scholar]
  • (45).Johnson KA, Simpson ZB, and Blom T (2009) Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data. Anal. Biochem 387, 20–29. [DOI] [PubMed] [Google Scholar]
  • (46).Lienhard GE, and Jencks WP (1966) Thiol addition to the carbonyl group: equilibria and kinetics. J. Am. Chem. Soc 88, 3982–3995. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

zhai and meek SI

RESOURCES